Diabetic neuropathies in brain are induced by deficiency of BDNF

被引:121
作者
Nitta, A
Murai, R
Suzuki, N
Ito, H
Nomoto, H
Katoh, G
Furukawa, Y
Furukawa, S
机构
[1] Gifu Pharmaceut Univ, Mol Biol Lab, Gifu 5028585, Japan
[2] Chiba Coll Hlth Sci, Dept Neuroanat, Chiba, Japan
[3] Aichi Bunkyo Womens Coll, Nishi, Inazawa, Japan
关键词
brain-derived neurotrophic factor; diabetes; learning memory; Y-maze task; rats;
D O I
10.1016/S0892-0362(02)00220-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Diabetes is known to be one of the risk factors for dementia; however, neuropathic changes in the brain of patients with the disease have not been completely revealed. So in the present study, we investigated the brain function of rats with diabetes induced by streptozotocin (STZ), one of the most commonly used animal models for diabetes. In the diabetic rats, immediately working memory performance was impaired in the Y-maze task and neuronal cytoskeleton proteins such as calbindin, synaptophysin, and syntaxin were reduced. Furthermore, morphological observation by Golgi staining showed a decrease in the number of basal dendrites and abnormality of spine structure. Next, we measured the content of brain-derived neurotrophic factor (BDNF) in the diabetic brain, because BDNF is one of the essential proteins for the maintenance of neuronal functions including synapse function and neuronal transmissions. In the diabetic brains, both protein and mRNA levels of BDNF were severely reduced. These results suggest that, in diabetes, synapse dysfunction is, at least in part, caused by a failure of BDNF synthesis in the brain. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:695 / 701
页数:7
相关论文
共 28 条
  • [1] Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance
    Curb, JD
    Rodriguez, BL
    Abbott, RD
    Petrovitch, H
    Ross, GW
    Masaki, KH
    Foley, D
    Blanchette, PL
    Harris, T
    Chen, R
    White, LR
    [J]. NEUROLOGY, 1999, 52 (05) : 971 - 975
  • [2] IMPAIRED NERVE REGENERATION IN STREPTOZOTOCIN-DIABETIC RATS IS IMPROVED BY TREATMENT WITH GANGLIOSIDES
    EKSTROM, PAR
    TOMLINSON, DR
    [J]. EXPERIMENTAL NEUROLOGY, 1990, 109 (02) : 200 - 203
  • [3] Feldman EL, 1997, CLIN NEUROSCI, V4, P365
  • [4] FERNYHOUGH P, 1995, J NEUROCHEM, V64, P1231
  • [5] Greene Douglas A., 1999, American Journal of Medicine, V107, p2S
  • [6] THE THERAPEUTIC EFFECTS OF 4-METHYLCATECHOL, A STIMULATOR OF ENDOGENOUS NERVE GROWTH-FACTOR SYNTHESIS, ON EXPERIMENTAL DIABETIC NEUROPATHY IN RATS
    HANAOKA, Y
    OHI, T
    FURUKAWA, S
    FURUKAWA, Y
    HAYASHI, K
    MATSUKURA, S
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 122 (01) : 28 - 32
  • [7] EFFECT OF 4-METHYLCATECHOL ON SCIATIC-NERVE GROWTH-FACTOR LEVEL AND MOTOR-NERVE CONDUCTION-VELOCITY IN EXPERIMENTAL DIABETIC NEUROPATHIC PROCESS IN RATS
    HANAOKA, Y
    OHI, T
    FURUKAWA, S
    FURUKAWA, Y
    HAYASHI, K
    MATSUKURA, S
    [J]. EXPERIMENTAL NEUROLOGY, 1992, 115 (02) : 292 - 296
  • [8] HARRIS Y, 1995, J NATL MED ASSOC, V87, P741
  • [9] Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects - A retrospective postmortem immunocytochemical and histofluorescent study
    Heitner, J
    Dickson, D
    [J]. NEUROLOGY, 1997, 49 (05) : 1306 - 1311
  • [10] Increase in syntaxin 1B and glutamate release in mossy fibre terminals following induction of LTP in the dentate gyrus: a candidate molecular mechanism underlying transsynaptic plasticity
    Helme-Guizon, A
    Davis, S
    Israel, M
    Lesbats, B
    Mallet, J
    Laroche, S
    Hicks, A
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (07) : 2231 - 2237